Resmed (RMD) Change in Receivables (2009 - 2026)
Resmed's (RMD) quarterly Change in Receivables came in at $16.9 million in Q1 2026, down 57.89% YoY from $40.0 million in Q1 2025, and down 76.81% on a QoQ basis from $72.7 million in Q4 2025.
Resmed (RMD) Change in Receivables (2009 - 2026) Analysis & Trends
Resmed (RMD) has 18 years of Change in Receivables data on file, last reported at $16.9 million in Q1 2026.
- Quarterly Change in Receivables fell 57.89% year-over-year to $16.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $64.8 million (down 49.78% YoY) and the FY2025 annual result came in at $76.7 million, down 42.89% from the prior year.
- Change in Receivables retreated to $16.9 million in Q1 2026, from $72.7 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $78.8 million in Q2 2022 to a low of -$36.4 million in Q3 2024.
- A 5-year average of $25.9 million and a median of $19.6 million in 2022 frame the typical range for Change in Receivables.
- The widest YoY moves for Change in Receivables: up 347.27% in 2024, down 457.35% in 2024.
- Tracing RMD's Change in Receivables over 5 years: stood at $19.6 million in 2022, then jumped by 36.85% to $26.8 million in 2023, then soared by 153.15% to $67.9 million in 2024, then climbed by 7.12% to $72.7 million in 2025, then tumbled by 76.81% to $16.9 million in 2026.
- The last three Change in Receivables figures came in at $16.9 million (Q1 2026), $72.7 million (Q4 2025), and -$30.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 74.90 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 37.21 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 2.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 252.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 156.00 Mn |
| 10 | Align Technology | 11.61 Bn | 10.51 Bn | 757.43 Mn | 31.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 37.21 Mn |
| Jun 30, 2026 | 37.21 Mn |
| Mar 31, 2026 | 16.86 Mn |
| Mar 31, 2026 | 16.86 Mn |
| Dec 31, 2025 | 72.68 Mn |
| Dec 31, 2025 | 72.68 Mn |
| Sep 30, 2025 | -29.97 Mn |
| Sep 30, 2025 | -29.97 Mn |
| Jun 30, 2025 | 5.22 Mn |
| Jun 30, 2025 | 5.22 Mn |
| Mar 31, 2025 | 40.03 Mn |
| Mar 31, 2025 | 40.03 Mn |
| Dec 31, 2024 | 67.85 Mn |
| Dec 31, 2024 | 67.85 Mn |
| Sep 30, 2024 | -36.42 Mn |
| Sep 30, 2024 | -36.42 Mn |
| Jun 30, 2024 | 57.52 Mn |
| Jun 30, 2024 | 57.52 Mn |
| Mar 31, 2024 | 56.49 Mn |
| Mar 31, 2024 | 56.49 Mn |